Pediatric and Geriatric Compounding – Laboratory Training
Both pediatric and geriatric patients present with similar concerns regarding medication intake, most notably, difficulty in swallowing a
tablet or capsule, or the requirement for a lower dosage strength than is commercially available. Such a challenge places compounding
in high demand as a means to achieve alternate dosage strengths and dosage forms in order to meet the unique needs of these patient
populations. The most common dosage form prescribed to pediatric and geriatric patients are oral liquids because they circumvent the
challenges of swallowing a tablet or capsule and allow for flexible dosing. Alternatively, child-friendly dosage forms, such as gummies,
offers a unique avenue that the compounding pharmacist can take.
In this laboratory training, participants will be exposed to detailed procedures required to uphold exceptional compounding quality in the
niche area of pediatric and geriatric therapy. With the implementation of innovative technologies and techniques, compounders will leave
this course with the tools and knowledge needed to further their compounding practice.
- Riboflavin 100 mg Oral Gummy Gels
- Omeprazole 2 mg/mL Oral Liquid
- Amlodipine Besylate 1 mg/mL Oral Liquid
Note: Formulas are subject to change.
DURATION: 4 HOURS
SHANNON BELLEVUE, BSc, MSc
Medical Editor Team Lead, LP3 Network
TAMMY NGUYEN BPHARM, MPS
Compounding Pharmacist, MEDISCA Australia
Disclosure: MEDISCA Australia Employee
JENNIFER CLARE, BSc
Laboratory Facilitator, LP3 Network
Senior Technical Support Service Representative,
MEDISCA Network Inc
Tammy Nguyen, BPharm
Compounding Pharmacist, MEDISCA Australia.
Rebecca O’Grady, BPharm, GradCertPharmPrac
Technical Support Services Representative, MEDISCA Australia.
Patricia Ullmann, BPharm
Training and Support Services Manager, MEDISCA Australia.
Activity material is Copyright© 2008-2019 LP3 Network Inc.
Activity participants are required to achieve a 75% passing grade
associated with a self-study learning assessment prior to attending the
live event. Full attendance and the completion of an activity evaluation
and practical skill set competency evaluation are a compulsory
requirement to achieve credit for the live event.
DECLARATIONS AND DISCLOSURES
This activity is independent of any known bias, prejudice or commercial interest. Both MEDISCA Australia and LP3 Network Inc. assist
with the marketing of this activity. LP3 Network Inc. is an independent corporation. LP3 Network Inc. has an established agreement with
MEDISCA AUSTRALIA ensuring that it has no influence on LP3 Network Inc. as it relates to activity offerings.
An unrestricted educational grant has been provided by MEDISCA Inc. toward the purchase of electromechanical equipment, reusable
and disposable devices, protective and safety supplies, and chemicals specific to compounded medications prepared during laboratory
Special rates for hotel accommodations have been arranged for activity participants. Payment for hotel accommodations is at the expense
of the activity participant.
CANCELLATION AND REFUND POLICY
A written request must be sent to MEDISCA Australia requesting a ‘Cancellation without Transfer’ to an alternate live activity event date. If
cancellation occurs at greater than or equal to 31 days from the live activity event date, then the registrant will receive a 75% refund; 15-30
days is a 50% refund; and less than or equal to 14 days will result in no refund.
The transfer policy is only in effect if requested less than or equal to 15 days post original live activity event date. Failure to submit the
“Transfer Request” within 15 days post original live activity event date will default to the “Cancellation and Refund Policy”. The transfer
policy can only be applied one (1) time. Transfer to a new live activity event date must be within the current calendar year. Failure to attend
the new live activity event will result in no refund and will no longer be transferable. Confirmation of the new activity date is subject to
approval by MEDISCA Australia based on the number of available seats within the selected live activity event.